Scarica l'app Stockscreener
63.93
0.92%
0.58
Dopo l'orario di chiusura:
63.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$63.35
Aprire:
$63.12
Volume 24 ore:
318.81K
Relative Volume:
0.92
Capitalizzazione di mercato:
$1.38B
Reddito:
$486.82M
Utile/perdita netta:
$18.78M
Rapporto P/E:
77.96
EPS:
0.82
Flusso di cassa netto:
$100.45M
1 W Prestazione:
-5.26%
1M Prestazione:
+0.58%
6M Prestazione:
+9.02%
1 anno Prestazione:
+0.13%
Intervallo 1D:
$62.67
$64.38
Intervallo di 1 settimana:
$62.60
$68.18
Portata 52W:
$52.50
$77.00
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Nome
Ani Pharmaceuticals Inc
Settore
Telefono
(218) 634-3500
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Confronta ANIP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
63.93 | 1.37B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-03-12 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Iniziato | Leerink Partners | Outperform |
| 2024-10-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-15 | Iniziato | CapitalOne | Overweight |
| 2023-08-22 | Reiterato | H.C. Wainwright | Buy |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-02 | Iniziato | Truist | Buy |
| 2020-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-05-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Reiterato | Canaccord Genuity | Buy |
| 2017-07-31 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-22 | Downgrade | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Iniziato | Raymond James | Strong Buy |
| 2016-05-24 | Downgrade | Standpoint Research | Buy → Hold |
| 2015-11-13 | Iniziato | Standpoint Research | Buy |
| 2015-09-28 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Reiterato | Oppenheimer | Outperform |
| 2015-08-04 | Reiterato | ROTH Capital | Neutral |
| 2015-07-31 | Reiterato | Oppenheimer | Outperform |
| 2015-07-15 | Reiterato | ROTH Capital | Neutral |
| 2015-06-23 | Reiterato | Oppenheimer | Outperform |
| 2015-05-18 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Reiterato | Oppenheimer | Outperform |
| 2015-04-10 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Reiterato | ROTH Capital | Buy |
| 2015-02-18 | Reiterato | Oppenheimer | Outperform |
Mostra tutto
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
How does ANI Pharmaceuticals Inc. compare to its industry peersBuild wealth steadily with smart stock selection - jammulinksnews.com
What analysts say about ANI Pharmaceuticals Inc. stockMaximize gains with timely market signals - jammulinksnews.com
What is ANI Pharmaceuticals Inc. company’s growth strategyExplosive trading opportunities - jammulinksnews.com
What are the latest earnings results for ANI Pharmaceuticals Inc.High-profit trading signals - jammulinksnews.com
Is ANI Pharmaceuticals Inc. a good long term investmentBoost your wealth with consistent growth stocks - jammulinksnews.com
How many analysts rate ANI Pharmaceuticals Inc. as a “Buy”Get professional guidance for market timing - jammulinksnews.com
What drives ANI Pharmaceuticals Inc. stock priceUnlock daily trading alerts for profits - jammulinksnews.com
What is the dividend policy of ANI Pharmaceuticals Inc. stockRealize consistent double-digit growth - jammulinksnews.com
How volatile is ANI Pharmaceuticals Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
ANI Pharmaceuticals Inc. Stock Analysis and ForecastUnlock steady growth with low-risk stocks - jammulinksnews.com
Should I hold or sell ANI Pharmaceuticals Inc. stock in 2025Exceptional profit potential - jammulinksnews.com
What makes ANI Pharmaceuticals Inc. stock price move sharplyAccelerate your capital gains today - jammulinksnews.com
Is ANI Pharmaceuticals Inc. stock overvalued or undervaluedCapitalize on market momentum for maximum profit - jammulinksnews.com
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET - GlobeNewswire
How strong is ANI Pharmaceuticals Inc. company’s balance sheetEntry Signal Tracker For Consistent Profits - jammulinksnews.com
ANI Pharmaceuticals Sets Q2 2025 Earnings Call Date: Key Executive Team to Present Financial Results - Stock Titan
What are ANI Pharmaceuticals Inc. company’s key revenue driversAdvanced Screener Planner For Consistent Profits - jammulinksnews.com
Lacklustre Performance Is Driving ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Low P/S - 富途牛牛
ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 107% over 5 years despite pulling back 4.3% in the past week - simplywall.st
ANI Pharmaceuticals (NASDAQ:ANIP) pulls back 4.3% this week, but still delivers shareholders strong 16% CAGR over 5 years - Yahoo.co
Does ANI Pharmaceuticals Inc. stock perform well during market downturnsEntry Signal Guidance With Proven Results - jammulinksnews.com
Real time scanner hits for ANI Pharmaceuticals Inc. explainedSmart Allocation Stock Pick Insights Gaining Interest - metal.it
ANI Pharmaceuticals Challenges Court Verdict on Royalty Payment Agreement - AInvest
ANI Pharmaceuticals to Challenge Court Verdict - The Globe and Mail
Can ANI Pharmaceuticals Inc. Rally Enough to Break EvenTrend Analysis for Safer Trades Gains Popularity - metal.it
Is ANI Pharmaceuticals Inc. stock poised for growthFast Gaining Stock Screener Reports Released - metal.it
Short Covering May Lift ANI Pharmaceuticals Inc. in Near TermSmart Trade Plans With Risk Protection Explained - metal.it
Why ANI Pharmaceuticals Inc. stock attracts strong analyst attentionTriple Digit Return Forecasts - beatles.ru
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals By Investing.com - Investing.com South Africa
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals - Investing.com Australia
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals - The Manila Times
CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug - Stock Titan
Published on: 2025-07-29 19:34:49 - metal.it
Is ANI Pharmaceuticals (ANIP) a High-Probability Earnings Beat Candidate in Q2 2025? - AInvest
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release - Yahoo Finance
Published on: 2025-07-29 03:23:31 - metal.it
ANI Pharmaceuticals: Classic Case Of Capital Intensive Growth Hampering Value (NASDAQ:ANIP) - Seeking Alpha
How does ANI Pharmaceuticals Inc. generate profit in a changing economySkyrocketing returns - jammulinksnews.com
Is ANI Pharmaceuticals Inc. a growth stock or a value stockPhenomenal capital gains - jammulinksnews.com
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):